Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03830957
Other study ID # HFRC_01
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 26, 2018
Est. completion date December 2019

Study information

Verified date April 2019
Source Rajaie Cardiovascular Medical and Research Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the effects of Ivabradine and metoprolol to reduce heart rate prior to coronary CT angiography in patients with advanced heart failure.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date December 2019
Est. primary completion date December 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Sinus rhythm

- Heart rate >60/min

Exclusion Criteria:

- Atrial fibrillation

- Any contraindication for beta-blocker use

Study Design


Intervention

Drug:
Ivabradine
7.5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 7.5 mg
Metoprolol
5 mg oral single dose if the heart rate would not reach to 60/minute then give another dose, 5 mg

Locations

Country Name City State
Iran, Islamic Republic of Ahmad Amin Tehran

Sponsors (1)

Lead Sponsor Collaborator
Rajaie Cardiovascular Medical and Research Center

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Heart rate Changing heart rate during imaging study 30 minutes before and after coronary CT angiography
Secondary Dyspnea Shortness of breath, or "dyspnea", is the most famous symptom of left ventricular failure. It typically appears during strenuous activities, and progresses to ordinary activities, less than ordinary activities and ultimately resting state. The severity is categorized as above (FC 1 to 4) 30 minutes before and after coronary CT angiography and 6 months later
Secondary Functional calss Heart Failure severity has been classified according to New York Heart Association (NYHA) to:
Class I: No limitation of physical activity. Ordinary physical activity does not cause symptoms of HF.
Class II: Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in symptoms of HF.
Class III: Marked limitation of physical activity. Comfortable at rest, but less than ordinary activity causes symptoms of HF.
Class IV: Unable to perform any physical activity without symptoms of HF, or symptoms of HF at rest.
30 minutes before and after coronary CT angiography and 6 months later
Secondary Blood pressure, systolic and diastolic The amount of blood pressure measured by sphygmomanometer 30 minutes before and after coronary CT angiography and 6 months later
Secondary Sleep quality The rate of disturbed sleep measured as better than before, Worse than before, and No change
There are no standard classification for severity of this symptom. In our study, we measure this symptom as :
Better than before (1)
Worse than before (2)
No change (0)
Before CT angiography and 6 months later
Secondary Appetite The rate of changing in appetite level measured as better than before, Worse than before, and No change
Loss of appetite is a common symptom of heart failure. There are no standard classification for severity of this symptom. In our study, we measure this symptom as :
Better than before (1)
Worse than before (2)
No change (0)
Before CT angiography and 6 months later
Secondary Prolonged bradycardia Persistence of Bradycardia more than 6 hours is called prolonged bradycardia. 30 minutes before and after coronary CT angiography
Secondary Hypotension Systolic less than 80 mm Hg 30 minutes before and after coronary CT angiography
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy